Harrow (HROW) EBT Margin Growth (3y) (2016 - 2026)
Harrow (HROW) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | -1,176.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,176.00 |
| Mar 31, 2026 | -3,583.00 |
| Dec 31, 2025 | 648.00 |
| Sep 30, 2025 | 2,959.00 |
| Jun 30, 2025 | 3,442.00 |
| Mar 31, 2025 | -2,615.00 |
| Dec 31, 2024 | 4,546.00 |
| Sep 30, 2024 | 3,598.00 |
| Jun 30, 2024 | 178.00 |
| Mar 31, 2024 | -4,063.00 |
| Dec 31, 2023 | -3,448.00 |
| Sep 30, 2023 | -6,821.00 |
| Jun 30, 2023 | -945.00 |
| Mar 31, 2023 | 8,281.00 |
| Dec 31, 2022 | -1,544.00 |
| Sep 30, 2022 | 6,301.00 |
| Jun 30, 2022 | -867.00 |
| Mar 31, 2022 | -10,323.00 |
| Dec 31, 2021 | -19,534.00 |
| Sep 30, 2021 | -2,110.00 |